Brian L. Durkin's most recent trade in Abbvie Inc was a trade of 11,182 Common Stock, $0.01 par value done at an average price of $154.3 . Disclosure was reported to the exchange on Feb. 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbbVie | Brian L. Durkin | VP, CONTROLLER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 154.28 per share. | 28 Feb 2023 | 11,182 | 33,149 (0%) | 0% | 154.3 | 1,725,159 | Common Stock, $0.01 par value |
| AbbVie | Brian L. Durkin | VP, CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 16,042 | 35,136 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 6,752 | 6,752 | - | - | Option (right to buy) | |
| AbbVie | Brian L. Durkin | VP, CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 3,743 | 38,879 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 3,146 | 42,025 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 2,306 | 44,331 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.02 per share. | 09 Mar 2022 | 11,682 | 37,722 (0%) | 0% | 79.0 | 923,112 | Common Stock, $0.01 par value |
| AbbVie | Brian L. Durkin | VP, Controller | Sale of securities on an exchange or to another person at price $ 150.01 per share. | 09 Mar 2022 | 11,682 | 26,040 (0%) | 0% | 150.0 | 1,752,396 | Common Stock, $0.01 par value |
| AbbVie | Brian L. Durkin | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2022 | 11,682 | 0 | - | - | Option (Right to Buy) | |
| AbbVie | Brian L. Durkin | VP, Controller | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 09 Mar 2022 | 6,946 | 19,094 (0%) | 0% | 150.0 | 1,041,906 | Common Stock, $0.01 par value |
| AbbVie | Brian L. Durkin | VP, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 149.54 per share. | 25 Feb 2022 | 7,589 | 26,040 (0%) | 0% | 149.5 | 1,134,859 | Common Stock, $0.01 par value |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 10,945 | 10,945 | - | - | Option (Right to Buy) | |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 8,730 | 25,235 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,743 | 30,875 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 2,754 | 33,629 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 1,897 | 27,132 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, Controller | Sale of securities on an exchange or to another person at price $ 128.51 per share. | 20 Dec 2021 | 11,790 | 16,505 (0%) | 0% | 128.5 | 1,515,133 | Common Stock, $0.01 par value |
| AbbVie | Brian L. Durkin | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 7,180 | 0 | - | - | Option (right to buy) | |
| AbbVie | Brian L. Durkin | VP, Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.36 per share. | 20 Dec 2021 | 7,180 | 28,295 (0%) | 0% | 61.4 | 440,565 | Common Stock, $0.01 par value |
| AbbVie | Brian L. Durkin | VP, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.74 per share. | 28 Feb 2021 | 2,392 | 21,115 (0%) | 0% | 107.7 | 257,714 | Common Stock, $0.01 par value |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 15,527 | 15,527 | - | - | Option (right to buy) | |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 3,743 | 23,507 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 1,955 | 17,293 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 1,897 | 19,764 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Brian L. Durkin | VP, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 574 | 17,867 (0%) | 0% | 0 | Common Stock, $0.01 par value |